ClinicalTrials.gg
RecruitingNCT06638801BUILDUpdated Jul 16, 2026

Brain Uptrain to Improve Learning and Development

An interventional study of Coach-led caregiver-implemented early literacy and developmental programming and Reach Out and Read Training in Term Infant and Late Preterm Infant, sponsored by University of Alabama at Birmingham. Recruiting at 1 site in United States. Open to participants aged 1 Day to 7 Days. Per ClinicalTrials.gov, last updated 2026-07-16.

Sponsored by University of Alabama at Birmingham · Not applicable, Interventional, and Other

From the registry’s dates

  • Started Feb 2025; still recruiting 1 year 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
188
Allocation
Randomized
Ages
1 Day to 7 Days
Sex
All
01

Study summary

The purpose of this study is to see if an early literacy and developmental program in addition to shared reading can increase developmental test scores at 24 months of age. All caregivers of infants in this study will receive shared reading training. Half of the caregivers will be trained in an additional coach-led caregiver-implemented early literacy and numeracy program. Information related to infant development will be collected from parent surveys, medical records, and questionnaires and assessments.

Read the detailed description

This study will test the hypothesis that in term or late preterm infants who are discharged home from the newborn nursery, a coach-led caregiver-implemented early literacy and developmental program in addition to shared reading, compared with shared reading alone, will increase the Ages and Stages Questionnaire® score at 24 months. This will be a double blind randomized controlled trial with 1:1 parallel allocation using stratified permuted block design. Randomization will be stratified by gestational age (≥ 35 to \<38 weeks and ≥ 38 weeks). Randomization of twins and higher orders (when eligible) will be to the same group. Term and late preterm infants ≥ 35 weeks' gestation admitted to the newborn nursery are eligible for inclusion if they are being discharged home. We will exclude infants admitted to the NICU, infants with a known syndrome or major malformation, infants in DHR custody, infants enrolled in a competing study, and infants of families with a primary language other than English or Spanish. All study participants will receive shared reading information at scheduled well-child checks. Caregivers of infants in the intervention group will receive additional coach-led caregiver-implemented early literacy and developmental program. We will complete an ASQ-3 online or by telephone at 12 months, 24 months, and 36 months. We will also measure early literacy at 3 years, 4 years, and 5 years. The primary outcome will be the ASQ-3 scores at 24 months.

02

Conditions studied

  • Term Infant
  • Late Preterm Infant

Browse trials for

Keywords

  • maternal training
  • cognitive scores
  • reading
  • literacy
  • numeracy
03

In context

Literacy

201 studies on the registry are indexed under Literacy; 69 are open to participants now.

This study's planned enrollment of 188 is above the median of 124 across 170 interventional studies indexed under Literacy.

Browse Literacy studies →

Lead sponsor

University of Alabama at Birmingham is the lead sponsor of 1,421 studies on the registry; 277 are open to participants now.

Of its 164 completed or terminated interventional studies of FDA-regulated products, 130 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Day to 7 Days
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria: inborn at UAB, delivered at more than 35 weeks' gestation, planned for discharge home after initial hospitalization.

-

Exclusion Criteria: a major malformation, a known syndrome, admitted to the NICU, in DHR custody, enrolled in a competing study, and family's primary language is other than English or Spanish.

-

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
188 participants (estimated)

Study arms

  • Experimental
    Reach Out and Read plus intervention

    Reach Out and Read Training in addition to coach-led caregiver-implemented early literacy and developmental program

    Behavioral: Coach-led caregiver-implemented early literacy and developmental programming · Behavioral: Reach Out and Read Training

  • Active comparator
    Reach out and Read only

    Reach Out and Read at well child visits

    Behavioral: Reach Out and Read Training

Interventions

  • BehavioralCoach-led caregiver-implemented early literacy and developmental programming

    Caregivers will receive training about child brain development in the first 3 years of life. The training will emphasize the areas of spoken words, physical education, pointer-finger concept, focus and label, reading lessons, and mathematics.

  • BehavioralReach Out and Read Training

    Reach Out and Read parent training

06

What researchers measure

Primary outcomes

  1. ASQ-3 scores

    The total Ages and Stages Questionnaires 3rd Edition score at 24 months

    Time frame: 24 month well-child visit

Secondary outcomes

  1. ASQ-3 scores

    The total Ages and Stages Questionnaires 3rd Edition score at 12 months

    Time frame: 12 month well-child visit

  2. ASQ-3 scores

    The total Ages and Stages Questionnaires 3rd Edition score at 36 months

    Time frame: 36 month well-child visit

  3. ASQ scores below -2SD

    The proportion of children with Ages and Stages Questionnaires 3rd Edition 2 standard deviations of more below the mean at 12 months

    Time frame: 12 month well-child visit

  4. ASQ scores below -2SD

    The proportion of children with Ages and Stages Questionnaires 3rd Edition 2 standard deviations of more below the mean at 24 months

    Time frame: 24 month well-child visit

  5. ASQ scores below -2SD

    The proportion of children with Ages and Stages Questionnaires 3rd Edition 2 standard deviations of more below the mean at 36 months

    Time frame: 36 month well-child visit

  6. ASQ scores below -1SD

    The proportion of children with Ages and Stages Questionnaires 3rd Edition one standard deviation of more below the mean at 12 months

    Time frame: 12 month well-child visit

  7. ASQ scores below -1SD

    The proportion of children with Ages and Stages Questionnaires 3rd Edition one standard deviation of more below the mean at 24 months

    Time frame: 24 month well-child visit

  8. ASQ scores below -1SD

    The proportion of children with Ages and Stages Questionnaires 3rd Edition one standard deviation of more below the mean at 36 months

    Time frame: 36 month well-child visit

  9. Literacy Scores

    Get Ready To Read- Revised, McArthur-Bates Communicative Development Inventory, Preschool Language Scales- Fifth Edition scores at 36 months

    Time frame: 36 months

  10. Literacy Scores

    Get Ready To Read- Revised, McArthur-Bates Communicative Development Inventory, Preschool Language Scales- Fifth Edition

    Time frame: 48 months

  11. Literacy Scores

    Get Ready To Read- Revised, McArthur-Bates Communicative Development Inventory, Preschool Language Scales- Fifth Edition scores at 60 months

    Time frame: 60 months

  12. Kindergarten Readiness

    Bracken School Readiness Assessment-Third Edition scores at 60 months

    Time frame: 60 months

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2025 (actual). Primary completion is estimated for Feb 2029, 48 months after the start.

Of 115 non-industry interventional studies with no phase under Literacy, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 20. This study's planned 48 months is above that.

Counting every sponsor, half of 117 studies reached it within 11 months; a quarter within 4 and three quarters within 19.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 10, 2024
First posted
Oct 15, 2024
StartActual
Feb 18, 2025
Primary completionEst.
Feb 18, 2029
CompletionEst.
Jun 18, 2031
Last update
Jul 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06638801
Responsible party
Colm Travers (Associate Professor, Neonatologist, University of Alabama at Birmingham) — Principal investigator
First posted
Oct 15, 2024
Start date
Feb 18, 2025
Primary completion
Feb 18, 2029 (estimated)
Completion
Jun 18, 2031 (estimated)
Last update
Jul 16, 2026

Study contacts

Colm Travers
Contact
cptravers@uabmc.edu
(205) 934-4680
Tamaryn Garcia
Contact
thgarcia@uabmc.edu
Colm P Travers
principal investigator · University of Alabama at Birmingham

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion